Skip to main content

Table 1 Demographic and clinical characteristics of study populations

From: Human rhinovirus infection causes different DNA methylation changes in nasal epithelial cells from healthy and asthmatic subjects

 

Population 1

Population 2

p value

 

Healthy (n = 7)

Asthma (n = 10)

Healthy (n = 6)

Asthma (n = 6)

Healthy (n = 13) Vs Asthma (n = 16)

Female - n (%)

6 (85.7)

6 (60.0)

1 (16.0)

4 (66.6)

1.00

Age - median (±SD)

23 (2.4)

26 (5.9)

20 (0.9)

31 (9.8)

0.02

BMI - median (±SD)

22 (3.9)

25 (9.7)

21 (1.5)

23 (5.0)

0.14

Ethnicity - n (%)

     

White

7 (100.0)

2 (20.0)

3 (50.0)

1 (16.6)

0.01

Hispanic

0

3 (30.0)

0

1 (16.6)

0.10

Black

0

3 (30.0)

0

2 (33.3)

0.04

Asian

0

2 (20.0)

3 (50.0)

1 (16.6)

1.00

Other

0

0

0

1 (16.6)

1.00

Atopy - n (%)

1 (14.2)

10 (100)

5 (83.3)

5 (83.3)

0.01

Allergic Rhinitis - n (%)

1 (14.2)

9 (90.0)

2 (33.3)

3 (50.0)

0.01

Chronic Rhinosinusitis - n (%)

1 (14.2)

1 (10.0)

1 (16.6)

2 (33.3)

1.00

Albuterol - n (%)

0

7 (70.0)

0

3 (50.0)

0.004

FEV1 - median (±SD % predicted)

101 (9.6)

85 (10.4)

95 (12.3)

92 (22.2)

0.09

FEV1/FEVC - median (±SD in L)

0.82 (0.04)

0.78 (0.60)

0.85 (0.03)

0.80 (0.03)

0.05

PEF - median (±SD in L/min)

7.06 (1.70)

6.98 (1.50)

7.21 (0.77)

7.47 (1.90)

0.82

  1. Albuterol was the only medication in use within the Asthma group. BMI- body mass index. SD- standard deviation. FEV1 – forced expiratory volume in one second. FVC – forced vital capacity. PEF – Peak expiratory Flow.